COVID-19 disease: a nephrologist’s perspective
Abstract
Novel Coronavirus disease (COVID-19) is a newly discovered contagious disease caused by severe acute respiratory syndrome (SARS)–coronavirus (CoV)-2 virus. It manifests primarily as an acute respiratory illness with interstitial and alveolar pneumonia, but it can affect multiple organs such as the kidney, heart, digestive tract, blood, and nervous system. Kidney involvement has been recognised as a serious complication of COVID -19 infection. Renal involvement can manifest from asymptomatic urinary abnormality to life-threatening dialysis requiring renal failure. . Risk factors for AKI included older age, diabetes mellitus, cardiovascular disease, black race, hypertension and need for ventilation and vasopressor medications. Asymptomatic Covid-19 infection is common in patients on Maintainance hemodialysis and would need strict precautions to prevent the spread of infection. Post kidney transplant covid 19 infection carries a high risk of allograft dysfunction and mortality.
Downloads
References
2. Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382:1708–20.
3. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323:1061–69.
4. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395:507–13.
5. Diao B, Wang C, Wang R, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection [preprint]. medRxiv. https://doi.org/10.1101/2020.03.04.20031120.Accessed April 19, 2020.
6. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395:1054–62.
7. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.
8. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8:475–81.
9. Hirsch JS, Ng JH, Ross DW, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209-218. doi: 10.1016/j.kint.2020.05.006.
10. Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, et al: Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98: 219–227, 2020.
11. Puelles VG, Lütgehetmann M, Lindenmeyer MT, et al. Multiorgan and Renal Tropism of SARS-CoV-2 [published online ahead of print, 2020 May 13]. N Engl J Med. 2020; NEJMc2011400. doi:10.1056/NEJMc2011400.
12.Larsen CP, Bourne TD, Wilson JD, Saqqa O, Sharshir MA: Collapsing glomerulopathy in a patient with coronavirus disease 2019 (COVID-19). Kidney Int Rep 5: 935–939, 20
13. Peleg Y, Kudose S, D’Agati V, Siddall E, Ahmad S, Kisselev S, et al: Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection. Kidney Int Rep 5: 940–945, 20.
14. Clarke C, Prendecki M, Dhutia A, Ali M, Sajjad H, Shivakumar O, Lightstone, L. Kelleher P, Pickering, Thomas D, Charif, R, Griffith M & Mcadoo S, Willicombe M. (2020). High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening. Journal of the American Society of Nephrology. ASN.2020060827. 10.1681/ASN.2020060827.
15.Nair, V, Jandovitz, N, Hirsch, JS, et al. COVID‐19 in kidney transplant recipients. Am Transplant. 2020; 20: 1819– 25.
This work is licensed under a Creative Commons Attribution 4.0 International License.
